Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Gordon

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Circulation. Cardiovascular Interventions|April 22, 2025
Impact of Calcified Raphe on TAVR in Bicuspid Patients: Predicting Redo-TAVR Feasibility and Virtual Planning ImplicationsPavan Reddy, Fernando J Rodriguez-Weisson, Giorgio A Medranda, et al.
JACC. Cardiovascular Interventions|May 9, 2020
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Bicuspid Aortic Valve StenosisRon Waksman, Paige E Craig, Rebecca Torguson, et al.
American Heart Journal|March 13, 2021
Transcatheter aortic valve replacement in low-risk patients: 2-year results from the LRT trialRon Waksman, Rebecca Torguson, Giorgio A Medranda, et al.
Circulation. Cardiovascular Interventions|May 16, 2023
Transcatheter Aortic Valve Replacement and Impact of Subclinical Leaflet Thrombosis in Low-Risk Patients: LRT Trial 4-Year OutcomesRon Waksman, Sukhdeep Bhogal, Paul Gordon, et al.
Hematology (Amsterdam, Netherlands)|August 24, 2022
Efficacy and safety of blinatumomab in Chinese adults with Ph-negative relapsed/refractory B-cell precursor acute lymphoblastic leukemia: A multicenter open-label single-arm China registrational studyHongsheng Zhou, Qingsong Yin, Jie Jin, et al.
Blood|October 26, 2023
Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposureLinda Schönborn, Olga Esteban, Jan Wesche, et al.
JACC. Cardiovascular Interventions|March 21, 2020
Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR PatientsToby Rogers, Benjamin C Greenspun, Gaby Weissman, et al.
Journal of Medical Genetics|June 26, 2010
SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlationsStéphanie Millecamps, François Salachas, Cécile Cazeneuve, et al.
Journal of the American College of Cardiology|September 1, 2018
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic StenosisRon Waksman, Toby Rogers, Rebecca Torguson, et al.
Journal of Psychopharmacology (Oxford, England)|June 24, 2023
The New Zealand drug harms ranking study: A multi-criteria decision analysisRose Crossin, Lana Cleland, Chris Wilkins, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Circulation. Cardiovascular Interventions|April 22, 2025
Impact of Calcified Raphe on TAVR in Bicuspid Patients: Predicting Redo-TAVR Feasibility and Virtual Planning ImplicationsPavan Reddy, Fernando J Rodriguez-Weisson, Giorgio A Medranda, et al.
JACC. Cardiovascular Interventions|May 9, 2020
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Bicuspid Aortic Valve StenosisRon Waksman, Paige E Craig, Rebecca Torguson, et al.
American Heart Journal|March 13, 2021
Transcatheter aortic valve replacement in low-risk patients: 2-year results from the LRT trialRon Waksman, Rebecca Torguson, Giorgio A Medranda, et al.
Circulation. Cardiovascular Interventions|May 16, 2023
Transcatheter Aortic Valve Replacement and Impact of Subclinical Leaflet Thrombosis in Low-Risk Patients: LRT Trial 4-Year OutcomesRon Waksman, Sukhdeep Bhogal, Paul Gordon, et al.
Hematology (Amsterdam, Netherlands)|August 24, 2022
Efficacy and safety of blinatumomab in Chinese adults with Ph-negative relapsed/refractory B-cell precursor acute lymphoblastic leukemia: A multicenter open-label single-arm China registrational studyHongsheng Zhou, Qingsong Yin, Jie Jin, et al.
Blood|October 26, 2023
Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposureLinda Schönborn, Olga Esteban, Jan Wesche, et al.
JACC. Cardiovascular Interventions|March 21, 2020
Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR PatientsToby Rogers, Benjamin C Greenspun, Gaby Weissman, et al.
Journal of Medical Genetics|June 26, 2010
SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlationsStéphanie Millecamps, François Salachas, Cécile Cazeneuve, et al.
Journal of the American College of Cardiology|September 1, 2018
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic StenosisRon Waksman, Toby Rogers, Rebecca Torguson, et al.
Journal of Psychopharmacology (Oxford, England)|June 24, 2023
The New Zealand drug harms ranking study: A multi-criteria decision analysisRose Crossin, Lana Cleland, Chris Wilkins, et al.
Pageof 12